BLTE - CIK 0001889109
BELITE BIO, INC (BLTE) reported net income of -$77.61M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$77.61M | -114.7% |
| FY 2024 | -$36.14M | -14.3% |
| FY 2023 | -$31.63M | -150.1% |
| FY 2022 | -$12.65M | -30.9% |
| FY 2021 | -$9.67M | -68.0% |
| FY 2020 | -$5.75M | - |
BELITE BIO, INC (BLTE) reported net income of -$77.61M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, BELITE BIO, INC's net income declined from -$5.75M to -$77.61M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.